[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20044424L - Fremgangsmate for fremstilling av sertindol - Google Patents

Fremgangsmate for fremstilling av sertindol

Info

Publication number
NO20044424L
NO20044424L NO20044424A NO20044424A NO20044424L NO 20044424 L NO20044424 L NO 20044424L NO 20044424 A NO20044424 A NO 20044424A NO 20044424 A NO20044424 A NO 20044424A NO 20044424 L NO20044424 L NO 20044424L
Authority
NO
Norway
Prior art keywords
sertindole
procedure
preparation
Prior art date
Application number
NO20044424A
Other languages
English (en)
Other versions
NO330110B1 (no
Inventor
Marco Villa
Jacopo Zanon
Francesco Ciardella
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2003/000208 external-priority patent/WO2003080597A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20044424L publication Critical patent/NO20044424L/no
Publication of NO330110B1 publication Critical patent/NO330110B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
NO20044424A 2002-03-27 2004-10-19 Fremgangsmate for fremstilling av 5-klor-1-(4-fluorfenyl)-indol NO330110B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36843402P 2002-03-27 2002-03-27
DKPA200200480 2002-03-27
PCT/DK2003/000208 WO2003080597A1 (en) 2002-03-27 2003-03-26 Method for manufacture of sertindole

Publications (2)

Publication Number Publication Date
NO20044424L true NO20044424L (no) 2004-10-19
NO330110B1 NO330110B1 (no) 2011-02-21

Family

ID=28455830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044424A NO330110B1 (no) 2002-03-27 2004-10-19 Fremgangsmate for fremstilling av 5-klor-1-(4-fluorfenyl)-indol

Country Status (7)

Country Link
US (2) US20050101788A1 (no)
HK (1) HK1080855A1 (no)
HR (1) HRP20040987A2 (no)
IL (1) IL163992A0 (no)
IS (1) IS7450A (no)
MX (1) MXPA04009365A (no)
NO (1) NO330110B1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494142A1 (en) * 2002-08-02 2004-02-12 Rhodia Pharma Solutions Inc. Copper catalyzed arylation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3035403C2 (de) * 1980-09-19 1982-08-26 Rütgerswerke AG, 6000 Frankfurt Verfahren zur Herstellung von 5-Chlorindol
US4861880A (en) * 1982-09-20 1989-08-29 Pfizer Inc. 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents
US4476307A (en) * 1982-09-20 1984-10-09 Pfizer Inc. Heteroylidene indolone compounds
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
US5322851A (en) * 1990-07-02 1994-06-21 H. Lundbeck A/S Indole derivatives
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
US5298625A (en) * 1992-12-07 1994-03-29 E. R. Squibb & Sons, Inc. Process for the preparation of 4-phosphinyl-3-keto-carboxylate and 4-phosphonyl-3-keto-carboxylate intermediates useful in the preparation of phosphorus containing HMG-CoA reductase inhibitors

Also Published As

Publication number Publication date
IL163992A0 (en) 2005-12-18
US20050101788A1 (en) 2005-05-12
HK1080855A1 (en) 2006-05-04
MXPA04009365A (es) 2005-01-25
HRP20040987A2 (en) 2005-06-30
IS7450A (is) 2004-09-16
NO330110B1 (no) 2011-02-21
US20090264656A1 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
DK3384931T3 (da) Superfin formoterolformulering
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
NO20044916L (no) Preparater av sulfinylacetamid
DE50310866D1 (de) Flanschverbindung
IS7528A (is) Nýir etónógestrel esterar
NO20051281D0 (no) Sammensetning for anrikning av naeringsmidler
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20041968L (no) Anvendelse av cystationin
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
NO20023445L (no) Fremgangsmåte for fremstilling av peptider
NO20034597L (no) Fremgangsmate for fremstilling av cantaxantin
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
NO20043948L (no) Fremstilling av olefiner
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
IS7537A (is) Notkun á nýjum etónógestrel esterum.
NO20043455L (no) Fremgangsmate for fremstilling av 7alfa-metylsteroider
DE50214840D1 (de) Ethylestern
NO20044424L (no) Fremgangsmate for fremstilling av sertindol
ITMI20030018A1 (it) Procedimento per la preparazione di composti mono-
FR2843451B1 (fr) Fronde du type lance-pierres

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

MM1K Lapsed by not paying the annual fees